Metabolic intervention targeting 6-phosphofructo-2-kinase/fructose-2,6-biphosphatase 3 (PFKFB3) using a structure-based design.

被引：0
|
作者：
Ahrlund-Richter, Lars
Farnegardh, Katarina
Wiita, Elisee
Jonsson, Mattias
Norstrom, Carina
Martinsson, Jessica
Hallberg, Kenth
Ringom, Rune
Mellstedt, Hakan
机构：
[1] Karolinska Inst, Dept Women & Childrens Hlth, Stockholm, Sweden
[2] Kancera AB, Solna, Sweden
[3] Sprint Biosci AB, Stockholm, Sweden
[4] Sprint Biosci, Stockholm, Sweden
[5] OncoTargeting AB, Uppsala, Sweden
[6] Karolinska Univ Hosp Solna, Stockholm, Sweden
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2012年 / 30卷 / 15期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
e13518
引用
收藏
页数：1
相关论文
共 50 条
  • [21] High expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (iPFK-2; PFKFB3) in human cancers
    Atsumi, T
    Chesney, J
    Metz, C
    Leng, L
    Donnelly, S
    Makita, Z
    Mitchell, R
    Bucala, R
    CANCER RESEARCH, 2002, 62 (20) : 5881 - 5887
  • [22] Functional Metabolic Screen Identifies 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 4 as an Important Regulator of Prostate Cancer Cell Survival
    Ros, Susana
    Santos, Claudio R.
    Moco, Sofia
    Baenke, Franziska
    Kelly, Gavin
    Howell, Michael
    Zamboni, Nicola
    Schulze, Almut
    CANCER DISCOVERY, 2012, 2 (04) : 328 - 343
  • [23] 6-Phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB3) is up-regulated in high-grade astrocytomas
    Renate Kessler
    Franziska Bleichert
    Jan-Peter Warnke
    Klaus Eschrich
    Journal of Neuro-Oncology, 2008, 86 : 257 - 264
  • [24] 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (PFKFB3) is up-regulated in high-grade astrocytomas
    Kessler, Renate
    Bleichert, Franziska
    Warnke, Jan-Peter
    Eschrich, Klaus
    JOURNAL OF NEURO-ONCOLOGY, 2008, 86 (03) : 257 - 264
  • [25] Targeting 6-phosphofructo-2-kinase (PFKFB3) as an immunotherapeutic strategy.
    Chesney, Jason Alan
    Telang, Sucheta
    Yaddanapudi, Kavitha
    Grewal, Jaspreet Singh
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [26] Targeting 6-Phosphofructo-2-kinase/Fructose-2,6-Bisphosphatase-4 (PFKFB4) in Cancer
    Telang, S.
    Trent, J.
    Chesney, J.
    Clark, J.
    FASEB JOURNAL, 2015, 29
  • [27] Small molecule 3PO inhibits glycolysis but does not bind to 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 (PFKFB3)
    Veseli, Besa Emini
    Perrotta, Paola
    Van Wielendaele, Pieter
    Lambeir, Anne-Marie
    Abdali, Anahita
    Bellosta, Stefano
    Monaco, Giovanni
    Bultynck, Geert
    Martinet, Wim
    De Meyer, Guido R. Y.
    FEBS LETTERS, 2020, 594 (18) : 3067 - 3075
  • [28] Partial Inhibition of the 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase-3 (PFKFB3) Enzyme in Myeloid Cells Does Not Affect Atherosclerosis
    Tillie, Renee J. H. A.
    De Bruijn, Jenny
    Perales-Paton, Javier
    Temmerman, Lieve
    Ghosheh, Yanal
    Van Kuijk, Kim
    Gijbels, Marion J.
    Carmeliet, Peter
    Ley, Klaus
    Saez-Rodriguez, Julio
    Sluimer, Judith C.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [29] Partial Inhibition of the 6-Phosphofructo-2-Kinase/Fructose-2,6-Bisphosphatase-3 (PFKFB3) Enzyme in Myeloid Cells Does Not Affect Atherosclerosis
    Tillie, Renee J. H. A.
    De Bruijn, Jenny
    Perales-Paton, Javier
    Temmerman, Lieve
    Ghosheh, Yanal
    Van Kuijk, Kim
    Gijbels, Marion J.
    Carmeliet, Peter
    Ley, Klaus
    Saez-Rodriguez, Julio
    Sluimer, Judith C.
    FRONTIERS IN CELL AND DEVELOPMENTAL BIOLOGY, 2021, 9
  • [30] Indole Alleviates Diet-Induced Hepatic Steatosis and Inflammation in a Manner Involving Myeloid Cell 6-Phosphofructo-2-Kinase/Fructose-2,6-Biphosphatase 3
    Ma, Linqiang
    Li, Honggui
    Hu, Jinbo
    Zheng, Juan
    Zhou, Jing
    Botchlett, Rachel
    Matthews, Destiny
    Zeng, Tianshu
    Chen, Lulu
    Xiao, Xiaoqiu
    Athrey, Giri
    Threadgill, David W.
    Li, Qingsheng
    Glaser, Shannon
    Francis, Heather
    Meng, Fanyin
    Li, Qifu
    Alpini, Gianfranco
    Wu, Chaodong
    HEPATOLOGY, 2020, 72 (04) : 1191 - 1203
12345